These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8882408)

  • 1. Substitutions in the HLA-DR alpha chain differentially affect DR7-restricted T-cell recognition of rabies virus antigen.
    Fu XT; Saibara T; Karr RW; Celis E
    Hum Immunol; 1996 Feb; 45(2):111-6. PubMed ID: 8882408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells.
    Karr RW; Yu W; Watts R; Evans KS; Celis E
    J Exp Med; 1990 Jul; 172(1):273-83. PubMed ID: 2358778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.
    Fu XT; Bono CP; Woulfe SL; Swearingen C; Summers NL; Sinigaglia F; Sette A; Schwartz BD; Karr RW
    J Exp Med; 1995 Mar; 181(3):915-26. PubMed ID: 7869051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
    Brawley JV; Concannon P
    J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
    Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
    J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.
    Celis E; Karr RW; Dietzschold B; Wunner WH; Koprowski H
    J Immunol; 1988 Oct; 141(8):2721-8. PubMed ID: 2459225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
    Jones CM; Lake RA; Lamb JR; Faith A
    Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.
    Fu XT; Karr RW
    Hum Immunol; 1994 Apr; 39(4):253-60. PubMed ID: 7520896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.